David-Alexandre Gros, based in San Diego, California, United States, is currently a Chief Executive Officer and Director at Eledon Pharmaceuticals, bringing experience from previous roles at Eliem Therapeutics, Imbria Pharmaceuticals, Pardes Biosciences and 4d Molecular Therapeutics. David-Alexandre Gros holds a 2000 - 2002 Master of Business Administration in Management @ Harvard Business School. With a robust skill set that includes Strategy, Pharmaceutical Industry, Business Development, Corporate Development, Venture Capital and more, David-Alexandre Gros contributes valuable insights to the industry. David-Alexandre Gros has 8 emails and 1 mobile phone number on RocketReach.